1992
Prophylactic Use of Apraclonidine for Intraocular Pressure Increase After Nd:YAG Capsulotomies
Silverstone D, Brint S, Olander K, Taylor R, McCarty G, deFaller J, Burk L. Prophylactic Use of Apraclonidine for Intraocular Pressure Increase After Nd:YAG Capsulotomies. American Journal Of Ophthalmology 1992, 113: 401-405. PMID: 1348396, DOI: 10.1016/s0002-9394(14)76162-8.Peer-Reviewed Original ResearchConceptsVehicle-treated groupIntraocular pressurePosterior capsulotomyYAG laser posterior capsulotomyIncidence of increaseMean maximal changeMasked clinical trialIntraocular pressure increaseLaser posterior capsulotomyYAG posterior capsulotomyTreatment armamentariumProphylactic effectYAG capsulotomyProphylactic useAdverse reactionsClinical trialsVisual functionRelative safetyCapsulotomyMaximal changeApraclonidineGroupMulticenterPatientsArmamentarium
1991
Evaluation of Once-Daily Levobunolol 0.25% and Timolol 0.25% Therapy for Increased Intraocular Pressure
Silverstone D, Zimmerman T, Choplin N, Mundorf T, Rose A, Stoecker J, Kelley E, Lue J. Evaluation of Once-Daily Levobunolol 0.25% and Timolol 0.25% Therapy for Increased Intraocular Pressure. American Journal Of Ophthalmology 1991, 112: 56-60. PMID: 1882923, DOI: 10.1016/s0002-9394(14)76213-0.Peer-Reviewed Original ResearchConceptsOpen-angle glaucomaLevobunolol groupTimolol groupOcular hypertensionIntraocular pressureThree-month study periodIncreased Intraocular PressureOcular hypotensive efficacyOverall mean decreaseMean heart rateHypotensive efficacyBlood pressureClinical trialsHeart rateMean decreaseTreatment groupsThree monthsPatientsStudy periodHypertensionGlaucomaGroupLevobunololTimololTherapy